REFERENCES
- Ford AR, Aronson JK, Grahame DG, Carver JG. The acute changes seen in cardiac glycoside receptor sites, 80Rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy: Pharmacological and therapeutic implications for chronic digoxin therapy. J Clin Pharamcol 1979; 8: 135–142.
- Graves SW, Brown B, Valdes R. An endogenous digoxin-like substance in patients with renal impairment. Ann Int Med 1983; 99: 604–608.
- Johannessen A, Rendtorff C, Poulsen S. Digoxin intoxication induced by verapamil in an uremic patient. Clin Nephrol 1985; 24: 158–159.
- Klein HO, Lang R, Weiss E, Segni EK, Libhaber C, Guerrero J, Kaplinsky E. The influence of verapamil on serum digoxin concentration. Circulation 1982; 65 (5): 998–1003.
- Lim CK, Rideout JM, Sheldon JWS. Determination of verapamil and norverapamil in serum by high-performance liquid chromatography. J Liquid Chromatogr 1983; 6: 887–893.
- Pedersen KE. The influence of calcium antagonists on plasma digoxin concentration. Acta Med Scand 1984; Suppl 681: 31–36.
- Pedersen KE, Dorph-Pedersen A, Hvidt S, Klitgaard NA, Nielsen-Kudsk F. Digoxin-verapamil interaction. Clin Pharm Ther 1981; 30: 311–316.
- Pedersen KE, Dorph-Pedersen A, Hvidt S, Klitgaard NA, Pedersen KK. The long-term effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjects. Eur J Clin Pharmacol 1982; 22: 123–127.
- Pedersen KE, Thayssen P, Klitgaard NA, Christiansen BD, Nielsen-Kudsk F. The influence of verapamil on digoxin inotropism and pharmacokinetics. Eur J Clin Pharmacol 1983; 25. 199–206.
- Reuning RH, Sams RA, Notavi RE. Run of pharma cokinetics in drug dosage adjustment. I. Pharmacologic effect, kinetics and apparent volume of distribution of digoxin. J Clin Pharmacol 1973; 13: 127–141.
- Shah CM, Winer RI. Verapamil kinetics during maintenance hemodialysis. Am J Nephrol 1985; 5: 338–341.